Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Self-Sampling could boost cervical cancer screening for women with HIV

NCT ID NCT06800664

Disease control Sponsor: Baylor University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time

Summary

This study tests a program to help women living with HIV in Ghana get screened for cervical cancer more easily. The program includes self-sampling kits, patient navigators, and training for healthcare providers. Researchers want to see if these tools increase screening rates and can be adopted by local clinics.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
behavioral intervention (self-sampling, 3R model, patient navigators, and implementation support strategies)
What this could lead to
If successful, this could make cervical cancer screening more accessible and routine for women with HIV in Ghana, potentially reducing cancer deaths in this high-risk group.
What could go wrong
This is an implementation study, not a direct treatment trial. Success depends on healthcare system adoption, and results may not apply to other regions or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 1,500 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2025

Expected to finish

May 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

25 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: General criteria * ability to give consent per Institutional Review Board stipulations * residing in the Central Region * having no medical characteristics that would interfere with the ability to participate fully * the willingness to participate in this study. (a) Healthcare provider eligibility: Inclusion criteria include an individual (no gender restrictions) who * possesses healthcare qualifications (i.e., patient navigators, physicians, nurses, health facility management), * works at the HIV health facility at study sites, * is ≥18 years old. (b) Eligibility for women living with HIV (Patients) * identified female at birth) who * are living with HIV between 25 and 65 years old (age consistent with WHO CC screening guidelines) * have never had CC screening (Pap or HPV test), * have not had a screening for the past 5 years Exclusion Criteria: * Women will be excluded if they are pregnant or have had a hysterectomy. * WLWH who have a cervix are the main target population to develop the HOPE toolkit. * Women who are below 25 and those who are above 65 years will be excluded.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cervical cancer screening are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cervical cancer screening HIV Implementation science Implementation strategies Intervention (training) condition Self-sampling

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University of Cape Coast

    RECRUITING

    Cape Coast, Central Region, Ghana

More trials for these conditions

Other studies related to the condition(s) this trial covers.